Kewaunee Scientific Corporation KEQU
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 277.22M | 282.00M | 287.75M | 285.52M | 263.18M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 277.22M | 282.00M | 287.75M | 285.52M | 263.18M |
| Cost of Revenue | 198.07M | 201.56M | 204.51M | 202.45M | 185.88M |
| Gross Profit | 79.15M | 80.44M | 83.23M | 83.07M | 77.30M |
| SG&A Expenses | 64.09M | 63.73M | 63.23M | 63.40M | 57.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 262.15M | 265.28M | 267.75M | 265.85M | 243.19M |
| Operating Income | 15.06M | 16.72M | 20.00M | 19.67M | 19.99M |
| Income Before Tax | 12.37M | 13.73M | 16.13M | 15.80M | 16.28M |
| Income Tax Expenses | 3.22M | 3.27M | 4.41M | 3.77M | 3.77M |
| Earnings from Continuing Operations | 9.15 | 10.47 | 11.72 | 12.03 | 12.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -918.00K | -847.00K | -640.00K | -285.00K | -199.00K |
| Net Income | 8.23M | 9.62M | 11.08M | 11.74M | 12.31M |
| EBIT | 15.06M | 16.72M | 20.00M | 19.67M | 19.99M |
| EBITDA | 21.39M | 23.00M | 26.02M | 25.66M | 25.21M |
| EPS Basic | 2.87 | 3.36 | 3.88 | 4.11 | 4.30 |
| Normalized Basic EPS | 2.38 | 2.70 | 3.30 | 3.36 | 3.49 |
| EPS Diluted | 2.76 | 3.22 | 3.72 | 3.94 | 4.13 |
| Normalized Diluted EPS | 2.29 | 2.59 | 3.17 | 3.22 | 3.35 |
| Average Basic Shares Outstanding | 11.48M | 11.45M | 11.44M | 11.44M | 11.45M |
| Average Diluted Shares Outstanding | 11.89M | 11.93M | 11.92M | 11.93M | 11.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |